Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. (SHE:300937)

SHE:300937 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	361.42	386.67	374.86	457.82	153.78	114.23
Short-Term Investments	-	4.12	0.83	-	-	-
Trading Asset Securities	0.5	1.5	4	7	-	-
Cash & Short-Term Investments	361.92	392.29	379.69	464.82	153.78	114.23
Cash Growth	35.72%	3.32%	-18.32%	202.27%	34.62%	-7.25%
Accounts Receivable	454.65	250.81	196.54	146.26	57.75	59.38
Other Receivables	78.86	83.99	67.62	15.93	25.6	6.44
Receivables	533.51	334.79	264.16	162.18	83.35	65.82
Inventory	501.68	516.66	561.24	446.78	468.23	337.78
Prepaid Expenses	-	-	-	-	-	0.13
Other Current Assets	146.66	142.24	171.35	190.01	126.33	91.15
Total Current Assets	1,544	1,386	1,376	1,264	831.68	609.12
Property, Plant & Equipment	149.07	161.35	154.05	164.95	174.76	163.22
Long-Term Investments	55.33	45.19	28.25	22.4	21.58	17.56
Goodwill	11.57	16.57	16.47	16.36	2.52	3.13
Other Intangible Assets	43.15	47.64	46.43	50.65	42.06	39.23
Long-Term Deferred Tax Assets	33.75	25.45	15.23	8.86	3.69	3.03
Long-Term Deferred Charges	28.91	32.75	43.92	13.76	5.34	4.08
Other Long-Term Assets	0.2	1.57	6.27	50.83	105.43	-
Total Assets	1,866	1,717	1,687	1,592	1,187	839.38
Accounts Payable	518.31	332.9	359.66	370.54	184.1	208.43
Accrued Expenses	12.69	32.07	31.98	22.19	10.98	7.2
Short-Term Debt	369.88	372.32	320.74	235.84	119.36	40.05
Current Portion of Leases	-	6.77	4.2	5.24	4.7	-
Current Income Taxes Payable	22.94	6.14	4.99	7.87	1.19	3.16
Current Unearned Revenue	46.04	49.82	53.57	78.85	29.77	21.02
Other Current Liabilities	51.91	37.93	25.98	32.18	27.9	18.3
Total Current Liabilities	1,022	837.94	801.12	752.7	378	298.15
Long-Term Leases	6.11	9.76	4.69	2.54	5.75	-
Long-Term Unearned Revenue	4.43	4.68	5	6.32	6.1	6.43
Long-Term Deferred Tax Liabilities	11.96	13.08	13.34	10.07	9.29	9.58
Other Long-Term Liabilities	0.84	0.35	6.88	-	-	-
Total Liabilities	1,045	865.81	831.02	771.64	399.13	314.15
Common Stock	95.67	95.67	95.67	95.67	95.67	71.75
Additional Paid-In Capital	474	474.01	474.01	475.62	475.56	231.26
Retained Earnings	261.94	279.86	284.55	244.15	202.28	215.02
Comprehensive Income & Other	-	-	-	-1.5	-	-
Total Common Equity	831.61	849.54	854.22	813.94	773.51	518.02
Minority Interest	-10.97	1.16	1.82	6.03	14.43	7.21
Shareholders' Equity	820.64	850.69	856.04	819.98	787.94	525.23
Total Liabilities & Equity	1,866	1,717	1,687	1,592	1,187	839.38
Total Debt	375.99	388.85	329.63	243.62	129.8	40.05
Net Cash (Debt)	-14.07	3.44	50.06	221.21	23.98	74.19
Net Cash Growth	-	-93.14%	-77.37%	822.60%	-67.68%	-10.80%
Net Cash Per Share	-0.15	0.04	0.52	2.32	0.26	1.03
Filing Date Shares Outstanding	95.67	95.67	95.67	95.67	95.67	71.75
Total Common Shares Outstanding	95.67	95.67	95.67	95.67	95.67	71.75
Working Capital	521.99	548.04	575.32	511.1	453.68	310.98
Book Value Per Share	8.69	8.88	8.93	8.51	8.09	7.22
Tangible Book Value	776.89	785.33	791.32	746.94	728.93	475.66
Tangible Book Value Per Share	8.12	8.21	8.27	7.81	7.62	6.63
Buildings	-	116.61	116.57	118.19	117.76	-
Machinery	-	94.01	82.31	81.99	78.87	-
Construction In Progress	-	0.5	2.21	1.84	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.